Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Musaelyan A.A., Nazarov V.D., Lapin S.V., Chistyakov I.V., Komarov I.V., Tkachenko O.U., Sogoyan M.V., Berdnik E.W., Mazing A.V., Emanuel W.L., Akopov A.L., Orlov S.V., Bagnenko S.F.
Background. Lung cancer is the most frequent cause of cancer mortality. The prevailing type is non-small cell lung cancer (NSCLC), in the treatment of which EGFR tyrosine kinase inhibitors are actively used, as well as a combination of BRAF and MEK inhibitors.…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Fedorova P.A., Nazarov V.D., Musaelyan A.A., Lapin S.V., Boriskova M.E., Farafonova U.V., Emanuel V.L.
Introduction. Thyroid cancer (TC) is the most prevalent cancer among malignant neoplasms of the organs of the endocrine system. Cytological categories Bethesda III–V of TC are considered to be the most difficult for making a diagnosis. Molecular genetic tests …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2019
Musaelyan A.A., Chistyakov I.V., Nazarov V.D., Lapin S.V., Sogoyan M.V., Khalchitsky S.E., Emanuel W.L., Lobachevskaya T.W., Akopov A.L.
Background. Genotyping of the tumor samples is necessary for a personalized approach in the treatment of patients with malignancies. The identification of somatic mutations in EGFR and KRAS genes can help to predict the course of the disease and to individuali…